VEGFR Inhibitor Tivozanib(AV-951,KRN951) CAS 475108-18-0

Unit Price: USD 100.0000 / Kilogram
Payment Type: L/C,T/T
Incoterm: CIF
Min. Order: 1 Kilogram
Delivery Time: 3 Days

Basic Info

Model No.:  475108-18-0

Additional Info

Packaging: 25KGS/DRUM

Productivity: 30T/Y


Transportation: Ocean,Land,Air

Place of Origin: CHINA

Supply Ability: 30T/Y

Certificate: YES

Product Description

Tivozanib(AV-951) cas number 475108-18-0 is an anti-tumor targeted therapy, a multi-target anti-angiogenesis inhibitor,as anti-cancer new drug, mainly used for the treatment of renal cancer, showing good curative effect in the first-line treatment of advanced renal cell carcinoma. The main target is vascular endothelial growth factor VEGFR 1, 2, 3, which acts to treat kidney tumor cells by inhibiting these three vascular endothelial growth factor receptors. The average survival time after taking tivozanib is 11.8 months. There was no deterioration in the month, and the effect of the patients with advanced kidney cancer who had undergone surgical removal of some kidneys could reach nearly 14.8 months. Phase III clinical trials of the drug confirmed that the average disease-free survival of the tivozanib-treated group was significantly better than the sorafenib control group regardless of whether the patient had previously received systematic anti-tumor therapy. Therefore, the market potential of Tivozanib is very broad. According to a drug expert's assessment, the drug may become a blockbuster drug after its market launch.
     In vivo studies have shown that tivozanib cas number 475108-18-0 can reduce the microvessel density of transplanted tumors and inhibit the level of VEGFR-2 phosphorylation in transplanted tumors, especially when the oral tivozanib concentration reaches 1 mg/kg. In the athymic mice, tivozanib almost inhibited the growth of all transplanted tumors, and the tumor growth inhibition rate (TGI) was >85%. Tivozanib acts on human xenograft models including the lung, thymus, colon, ovary, pancreas and prostate. A study of a murine peritoneal disseminated tumor model showed that tivozanib prolonged the lifespan of tumor-bearing mice.

Thera. Category:Anti-tumor

Cas No.: 475108-18-0


Molecular Formula:C22H19ClN4O5


Molecular Weight:454.86

Pharmacopeia: in house spe.

Specifications:Available on request

Packing:Export worthy packing

Material Safety Data Sheet:Available on request


Active Pharmaceutical Ingredients> Cas 90098-04-7,Rebamipide Named In Mucosta With GMP Standard
Active Pharmaceutical Ingredients> Functional Dyspepsia Treatment Acotiamide Hydrochloride Trihydrate CAS 773092-05-0
Active Pharmaceutical Ingredients> Acotiamide Hydrochloride For Gastric Motility Improvement CAS 185104-11-4
Contract Manufacturing> ASCORBYL GLUCOSIDE Used for Comesitc Additive CAS 129499-78-1
Pharmaceutical Intermediates> Anti-Ulcerative> 2-Aminothiazole-4-ethylformate For Making Acotiamide Cas 5398-36-7
Pharmaceutical Intermediates> Anti-Ulcerative> Acotiamide INT CAS NUMBER 185105-98-0
Pharmaceutical Intermediates> Anti-Cardiovascular> Azilsartan Used for Hypertension Treatment CAS 147403-03-0
Pharmaceutical Intermediates> Anti-Diabetes> Sitagliptin Phosphate Monohydrate Treated for Type 2 diabetes CAS Number 654671-77-9
Pharmaceutical Intermediates> Anti-Ulcerative> Cas 132210-24-3, 2-Amino-3-(1,2-dihydro-2-oxo-quinoline-4-yl)Propanoic acid Hydrochloride For Rebamipide
Pharmaceutical Intermediates> Anti-Ulcerative> Cas 1068-90-2 White Crystalline Powder Diethyl Acetamidomalonate For Rebamipide(DAAM)
Active Pharmaceutical Ingredients> 6027-23-2, Hordenine HCL Powder
Pharmaceutical Intermediates> Anti-Ulcerative> Cas 4876-10-2,4-Bromomethyl-2(1H)-quinolinone (BMQ) For Rebamipide/ Mucosta
Pharmaceutical Intermediates> Anti-Respiratory> CAS 2338-18-3, 2-Aminoindan hydrochloride For Making Indacaterol
Pharmaceutical Intermediates> Anti-Respiratory> CAS 312753-53-0/ 5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride Used for Indacaterol
Pharmaceutical Intermediates> Anti-Respiratory> 312753-53-0, Indacaterol Intermediate
Pharmaceutical Intermediates> Anti-Respiratory> 100331-89-3, Indacaterol Intermediate

© 2019 CHINA WAY. All Rights Reserved.  Taizhou Volsen Chemical Co., Ltd.,  Inc.   All rights reserved. site map.  sitemap.html